Mereo BioPharma Group plc - ADR (MREO) is lower by Tuesday morning, with the stock falling -1.88% in pre-market trading to 1.57.
MREO's short-term technical score of 92 indicates that the stock has traded more bullishly over the last month than 92% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, Mereo BioPharma Group plc - ADR ranks higher than 96% of stocks.
Mereo BioPharma Group plc - ADR has risen 2.56% over the past month, closing at $1.47 on September 19. During this period of time, the stock fell as low as $1.19 and as high as $1.54. MREO has an average analyst recommendation of Strong Buy. The company has an average price target of $4.33.
MREO has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on MREO!
Mereo BioPharma Group plc - ADR has a Long-Term Technical rank of 94. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 6% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, MREO ranks better than 138% of stocks.
